A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NCT07095114
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are: Is the Magic Ink as safe as standard tattoo ink Does Magic Ink continue to function and remain visible for radiation therapists during the treatment Participants will be consented and given a skin assessment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Ductal Carcinoma in Situ
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Last updated on ClinicalTrials.gov
- September 18, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Michigan · 1
- Karmanos Cancer Institute · Detroit, MI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.